Myotonic dystrophy (DM) is caused by the expansion of a CTG repeat. The repeat is in the 3' end of the dystrophia myotonia protein kinase gene (DMPK) and immediately 5"""""""" of the dystrophia myotonia associated homeobox protein (DMAHP) gene. It is still unknown whether the altered expression of either of these genes contributes to the DM phenotype. While a large amount of work from other labs has demonstrated that the CTG expansion affects the processing of the DMPK transcript, work in my lab has demonstrated that expression of the adjacent DMAHP gene is suppressed by the expanded repeat. Th investigator's have demonstrated that a well-defined hypersensitive site is positioned between the repeat and the promoter of the DMAHP gene. They have shown that the hypersensitive site contains transcriptional enhancer elements and the activity of these elements correlate with expression of the DMAHP gene suggesting that expansion of the repeat both eliminates the hypersensitive sit and suppresses expression of the adjacent DMAHP gene. These data support the broad hypothesis that the hypersensitive site is critical for the normal regulation of gene expression at the myotonic dystrophy locus, and that suppression of factor access to this region contributes to the myotonic dystrophy phenotype. The broad goals of this application are to characterize the regulatory and structural elements at the myotonic dystrophy locus and determine whether they have a role in the pathogenesis of myotonic dystrophy.
The specific aims of the application are to (1) characterize the regulatory elements of hypersensitive site enhancer and DMAHP promoter; (2) characterize the elements at the locus that establish nucleosome phasing and maintain the hypersensitive site; (3) determine whether inactivation of the DMAHP gene or the hypersensitive site enhancer contributes to the phenotype of myotonic dystrophy. The significance of the proposal is that this application will characterize the elements that regulate gene expression at the myotonic dystophy locus and determine the role of these elements in the pathophysiology of myotonic dystrophy, ultimately leading to the rational design of therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR045203-03
Application #
6171475
Study Section
Molecular Cytology Study Section (CTY)
Program Officer
Lymn, Richard W
Project Start
1998-09-01
Project End
2003-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
3
Fiscal Year
2000
Total Cost
$277,364
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Balog, Judit; Goossens, Remko; Lemmers, Richard J L F et al. (2018) Monosomy 18p is a risk factor for facioscapulohumeral dystrophy. J Med Genet 55:469-478
Campbell, Amy E; Shadle, Sean C; Jagannathan, Sujatha et al. (2018) NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins. Elife 7:
Campbell, Amy E; Belleville, Andrea E; Resnick, Rebecca et al. (2018) Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle. Hum Mol Genet 27:R153-R162
Hendrickson, Peter G; Doráis, Jessie A; Grow, Edward J et al. (2017) Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons. Nat Genet 49:925-934
Whiddon, Jennifer L; Langford, Ashlee T; Wong, Chao-Jen et al. (2017) Conservation and innovation in the DUX4-family gene network. Nat Genet 49:935-940
Campbell, Amy E; Oliva, Jonathan; Yates, Matthew P et al. (2017) BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells. Skelet Muscle 7:16
Shadle, Sean C; Zhong, Jun Wen; Campbell, Amy E et al. (2017) DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy. PLoS Genet 13:e1006658
van den Boogaard, Marlinde L; Lemmers, Richard J F L; Camaño, Pilar et al. (2016) Double SMCHD1 variants in FSHD2: the synergistic effect of two SMCHD1 variants on D4Z4 hypomethylation and disease penetrance in FSHD2. Eur J Hum Genet 24:78-85
Feng, Qing; Snider, Lauren; Jagannathan, Sujatha et al. (2015) A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy. Elife 4:
Balog, Judit; Thijssen, Peter E; Shadle, Sean et al. (2015) Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. Epigenetics 10:1133-42

Showing the most recent 10 out of 33 publications